Shaanxi Kanghui Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 472.23 million compared to CNY 375.14 million a year ago. Revenue was CNY 472.23 million compared to CNY 375.14 million a year ago.

Net income was CNY 9.22 million compared to CNY 16.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.16 a year ago. Diluted earnings per share from continuing operations was CNY 0.09 compared to CNY 0.16 a year ago.